Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

Jahn SC, Law ME, Corsino PE, Rowe TC, Davis BJ, Law BK.

Biochemistry. 2013 May 21;52(20):3489-501. doi: 10.1021/bi400047u. Epub 2013 May 9.

2.

Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening.

Ostrov DA, Hernández Prada JA, Corsino PE, Finton KA, Le N, Rowe TC.

Antimicrob Agents Chemother. 2007 Oct;51(10):3688-98. Epub 2007 Aug 6.

3.

Induction of petite mutants in yeast Saccharomyces cerevisiae by the anticancer drug dequalinium.

Schneider-Berlin KR, Bonilla TD, Rowe TC.

Mutat Res. 2005 May 2;572(1-2):84-97.

PMID:
15790492
5.

First-use risks.

Rowe TC.

CMAJ. 2003 May 27;168(11):1394. No abstract available.

6.

Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels.

Mainwaring MG, Rimsza LM, Chen SF, Gomez SP, Weeks FW, Reddy V, Lynch J, May WS, Kahn S, Moreb J, Leather H, Braylan R, Rowe TC, Fieniewicz KJ, Wingard JR.

Leuk Lymphoma. 2002 May;43(5):989-99.

PMID:
12148910
7.

DNA topoisomerase II is essential for preimplantation mouse development.

St Pierre J, Wright DJ, Rowe TC, Wright SJ.

Mol Reprod Dev. 2002 Mar;61(3):347-57.

PMID:
11835580
8.

DNA topoisomerase II distribution in mouse preimplantation embryos.

St Pierre J, Wright DJ, Rowe TC, Wright SJ.

Mol Reprod Dev. 2002 Mar;61(3):335-46.

PMID:
11835579
9.

Mitochondrial DNA metabolism targeting drugs.

Rowe TC, Weissig V, Lawrence JW.

Adv Drug Deliv Rev. 2001 Jul 2;49(1-2):175-87. Review.

PMID:
11377810
10.

Isolation of covalent enzyme-DNA complexes.

Rowe TC, Grabowski D, Ganapathi R.

Methods Mol Biol. 2001;95:129-35. No abstract available.

PMID:
11089226
11.
12.

Dequalinium induces a selective depletion of mitochondrial DNA from HeLa human cervical carcinoma cells.

Schneider Berlin KR, Ammini CV, Rowe TC.

Exp Cell Res. 1998 Nov 25;245(1):137-45.

PMID:
9828109
13.

DQAsomes: a novel potential drug and gene delivery system made from Dequalinium.

Weissig V, Lasch J, Erdos G, Meyer HW, Rowe TC, Hughes J.

Pharm Res. 1998 Feb;15(2):334-7.

PMID:
9523323
14.

Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum.

Weissig V, Vetro-Widenhouse TS, Rowe TC.

DNA Cell Biol. 1997 Dec;16(12):1483-92.

PMID:
9428797
15.

Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells.

Lawrence JW, Claire DC, Weissig V, Rowe TC.

Mol Pharmacol. 1996 Nov;50(5):1178-88.

PMID:
8913349
16.

An extended 10-day course of clomiphene citrate (CC) in women with CC-resistant ovulatory disorders.

Fluker MR, Wang IY, Rowe TC.

Fertil Steril. 1996 Nov;66(5):761-4.

PMID:
8893681
17.

Analysis of expressed sequence tags from Plasmodium falciparum.

Chakrabarti D, Reddy GR, Dame JB, Almira EC, Laipis PJ, Ferl RJ, Yang TP, Rowe TC, Schuster SM.

Mol Biochem Parasitol. 1994 Jul;66(1):97-104.

PMID:
7984191
19.

4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells.

Lawrence JW, Darkin-Rattray S, Xie F, Neims AH, Rowe TC.

J Cell Biochem. 1993 Feb;51(2):165-74.

PMID:
8440750
20.

Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.

Sullivan DM, Eskildsen LA, Groom KR, Webb CD, Latham MD, Martin AW, Wellhausen SR, Kroeger PE, Rowe TC.

Mol Pharmacol. 1993 Feb;43(2):207-16.

PMID:
8094226
21.

Prognostic factors in assessment and management of male infertility.

Duleba AJ, Rowe TC, Ma P, Collins JA.

Hum Reprod. 1992 Nov;7(10):1388-93.

PMID:
1291563
22.
23.

The effect of treatment on pregnancy among couples with unexplained infertility.

Collins JA, Milner RA, Rowe TC.

Int J Fertil. 1991 May-Jun;36(3):140-1, 145-52.

PMID:
1678368
24.

Phosphorylation of DNA topoisomerase II in a human tumor cell line.

Kroll DJ, Rowe TC.

J Biol Chem. 1991 Apr 25;266(12):7957-61.

25.

Drug sensitivity of heat-resistant mouse B16 melanoma variants.

Kroll DJ, Borgert CJ, Wiedmann TW, Rowe TC.

Radiat Res. 1990 Oct;124(1):15-21.

PMID:
2236492
26.
27.
28.

Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell line.

Sullivan DM, Latham MD, Rowe TC, Ross WE.

Biochemistry. 1989 Jun 27;28(13):5680-7.

PMID:
2550059
29.

Salpingitis isthmica nodosa: evidence it is a progressive disease.

McComb PF, Rowe TC.

Fertil Steril. 1989 Mar;51(3):542-5. No abstract available.

PMID:
2920856
30.
31.
32.

Female tubal sterilization.

Rowe TC, Pabuccu R.

Can Fam Physician. 1986 Aug;32:1639-43.

33.
34.

DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.

Rowe TC, Chen GL, Hsiang YH, Liu LF.

Cancer Res. 1986 Apr;46(4 Pt 2):2021-6.

36.

In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.

Yang L, Rowe TC, Nelson EM, Liu LF.

Cell. 1985 May;41(1):127-32.

PMID:
2986841
37.
38.

Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

Chen GL, Yang L, Rowe TC, Halligan BD, Tewey KM, Liu LF.

J Biol Chem. 1984 Nov 10;259(21):13560-6.

39.

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF.

Science. 1984 Oct 26;226(4673):466-8.

PMID:
6093249
40.

Identification of the breakage-reunion subunit of T4 DNA topoisomerase.

Rowe TC, Tewey KM, Liu LF.

J Biol Chem. 1984 Jul 25;259(14):9177-81.

41.

Purification and properties of nuclease gamma from Ustilago maydis.

Yarnall M, Rowe TC, Holloman WK.

J Biol Chem. 1984 Mar 10;259(5):3026-32.

42.

The action of clomiphene in stress-induced amenorrhea.

Rowe TC, Pride SM.

Am J Obstet Gynecol. 1984 Mar 1;148(5):613-6.

PMID:
6422762
43.

Cleavage of DNA by mammalian DNA topoisomerase II.

Liu LF, Rowe TC, Yang L, Tewey KM, Chen GL.

J Biol Chem. 1983 Dec 25;258(24):15365-70.

44.

Purification and properties of a topoisomerase from Ustilago maydis.

Rowe TC, Rusche JR, Brougham MJ, Holloman WK.

J Biol Chem. 1981 Oct 25;256(20):10354-61.

45.

Studies on nuclease alpha from Ustilago maydis.

Holloman WK, Rowe TC, Rusche JR.

J Biol Chem. 1981 May 25;256(10):5087-94.

46.

Purification and characterization of nuclease beta from Ustilago maydis.

Rusche JR, Rowe TC, Holloman WK.

J Biol Chem. 1980 Oct 10;255(19):9117-23.

47.

Antecedent factors and outcome in amenorrhea-galactorrhea.

Rowe TC, Shearman RP, Fraser IS.

Obstet Gynecol. 1979 Nov;54(5):535-43.

PMID:
574234

Supplemental Content

Support Center